Cargando…

Reply to “Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy”

Detalles Bibliográficos
Autores principales:	Coto‐Hernández, Rubén, Fábregas Ruano, María Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770774/ https://www.ncbi.nlm.nih.gov/pubmed/32302445 http://dx.doi.org/10.1111/jth.14852

Ejemplares similares

Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'
por: Tang, Ning
Publicado: (2020)

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
por: Tang, Ning, et al.
Publicado: (2020)

Decreased mortality among hospitalized coronavirus disease 2019 patients who underwent anticoagulant therapy with heparin
por: Yethindra, Vityala, et al.
Publicado: (2020)

Dermatologists’ Role in the Diagnosis and Management of Coronavirus Disease 2019 Coagulopathy
por: Shah, Payal, et al.
Publicado: (2020)

Covid-19-induced coagulopathy and observed benefits with anticoagulation
por: Karimzadeh, Sedighe, et al.
Publicado: (2020)

Reply: Coronavirus disease 2019 vaccines in pregnancy
por: Craig, Amanda M., et al.
Publicado: (2021)

The unique landscape of coronavirus disease 2019 coagulopathy and imminent bleedings at unusual sites: Pathophysiology matters
por: Paschou, Eleni, et al.
Publicado: (2022)

Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy
por: Turshudzhyan, Alla
Publicado: (2020)

Hemoglobin value may be decreased in patients with severe coronavirus disease 2019
por: Lippi, Giuseppe, et al.
Publicado: (2020)

In Reply — Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019
por: Temesgen, Zelalem, et al.
Publicado: (2021)

Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients
por: Wang, Ying, et al.
Publicado: (2020)

Reply: Anticoagulation Challenges in Cancer Patients
por: Fradley, Michael G.
Publicado: (2021)

Reply
por: Fernández-Codina, Andreu, et al.
Publicado: (2023)

Reply
por: Fernández-Codina, Andreu, et al.
Publicado: (2023)

Reply to ‘Coronavirus disease 2019 prevention, control and modelling metrics’
por: Chatterjee, Kaushik, et al.
Publicado: (2020)

Reply: Clinical studies on coronavirus disease 2019 (COVID-19) in the WHO registry network
por: Verma, Henu Kumar, et al.
Publicado: (2022)

Impact of vaccination status and anticoagulation on venous thromboembolism risk and outcomes in coronavirus disease 2019 patients
por: Volteas, Panagiotis, et al.
Publicado: (2023)

Coronavirus Disease 2019–Associated Coagulopathy
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Coronavirus Disease 2019-Associated Coagulopathy
por: Seo, Jun-Won, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio on admission is an independent risk factor for the severity and mortality in patients with coronavirus disease 2019
por: Wang, Shijie, et al.
Publicado: (2021)

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)

Severe coronavirus disease 2019 in children and young adults
por: Wilkes, Meredith, et al.
Publicado: (2020)

Platelet count in patients with severe coronavirus disease 2019
por: Kawada, Tomoyuki
Publicado: (2021)

Lymphocytes and Eosinophils Associated with the Coronavirus Disease-2019 Severity
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Reply to Letter to Editor: Potent Anticoagulants are Associated with a Higher All-cause Mortality Rate after Hip and Knee Arthroplasty
por: Sharrock, Nigel E., et al.
Publicado: (2008)

Focus on coronavirus disease 2019 associated coagulopathy
por: Yang, Xiang-Hong, et al.
Publicado: (2020)

Coagulopathy in elderly patients with coronavirus disease 2019
por: Yuan, Xueting, et al.
Publicado: (2020)

Reply to: “Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?””
por: Bril, Fernando, et al.
Publicado: (2021)

Circulating histones play a central role in COVID-19-associated coagulopathy and mortality
por: Shaw, Rebecca J., et al.
Publicado: (2021)

Targeting complement in severe coronavirus disease 2019 to address microthrombosis
por: Valga, Francisco, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia
por: Lahmer, T., et al.
Publicado: (2020)

In Reply to the Letter to the Editor Regarding “Coronavirus Disease 2019 (COVID-19) and Neurosurgery: Literature and Neurosurgical Societies Recommendations Update”
por: Raffa, Giovanni, et al.
Publicado: (2020)

Reply to the Letter to the Editor: infection control protocol inside computed tomography suites during coronavirus disease 2019 outbreak
por: Yamashiro, Tsuneo, et al.
Publicado: (2020)

Reply to: Coronavirus disease 2019 vaccine in pregnant women: not so far! The importance of counseling and the need for evidence-based data
por: Craig, Amanda M., et al.
Publicado: (2021)

Reply to cai et al regarding “vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis”
por: Kotlyar, Alexander M., et al.
Publicado: (2022)

Anticoagulation Strategies and Determining the Rate of Fatal Intracerebral Hemorrhage Associated With Venovenous Extracorporeal Membrane Oxygenation in Patients With Coronavirus Disease 2019
por: Kelly, Adam, et al.
Publicado: (2021)

Curcumin and Coagulopathy in the COVID19 Era
por: Suresh, Padmanaban S.
Publicado: (2020)

Comments on: The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality
por: Maruotti, Antonello, et al.
Publicado: (2020)

The role of a cytokine storm in severe coronavirus disease 2019 in pregnancy
por: Wang, Xiaoping, et al.
Publicado: (2020)

Dementia is Associated with Severe Coronavirus Disease 2019 (COVID-19) Infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ibfcc6a347dkpqtag0ncfp8e02